Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma
Immunologic treatment options are uncommon in low-grade gliomas, although such therapies might be beneficial for inoperable and aggressive cases.Knowledge of the immune and stromal cells in low-grade gliomas is highly relevant for such approaches but still needs to be improved.Published gene-expression data from 400 low-grade gliomas and 193 high-g